San Diego, CA — Qureator is proud to announce a new partnership with the Physicians Committee for Responsible Medicine (PCRM) to host an exclusive in-person workshop during the Society of Toxicology (SOT) 2026 Annual Meeting in San Diego. This collaboration reflects our shared commitment to advancing human-relevant, non-animal approaches in next-generation toxicology and risk assessment.
The workshop will provide participants with firsthand experience using Qureator’s next-generation vascularized organoids, part of our QuriCore® platform. Attendees will engage directly with our human-derived microphysiological systems, explore how these models enhance predictive accuracy in toxicology, and gain insight from Qureator scientists and PCRM policy leaders at the forefront of NAMs innovation.
In addition, participants will receive a guided tour of Qureator’s San Diego facility, offering an inside look at how our organ-on-a-chip technologies and AI-powered workflows are reshaping preclinical evaluation.
“We are thrilled to partner with PCRM to accelerate the adoption of human-specific, non-animal testing strategies,” said Kyu Baek, CEO and Co-Founder of Qureator. “Together, we aim to demonstrate how high-fidelity human models can drive safer, faster, and more ethical scientific progress.”
The free workshop is limited to 20 participants, and registration is required.